Vietnam Protein Therapeutics Market Size, Share, Trends and Forecast by Product, Therapy Area, Function, and Region, 2025-2033

Vietnam Protein Therapeutics Market Overview:

The Vietnam protein therapeutics market size reached USD 1.84 Billion in 2024. The market is projected to reach USD 3.16 Billion by 2033, exhibiting a growth rate (CAGR) of 5.58% during 2025-2033. The growth is fueled by the increasing demand for chronic and non-communicable diseases that need sophisticated therapeutic alternatives, continued government investment in healthcare facilities and biopharmaceutical production, and increased usage of biosimilar and biologic treatments among healthcare centers. Furthermore, the increased healthcare network and enhanced access to specialized care are propelling the Vietnam protein therapeutics market share.

Vietnam Protein Therapeutics Market Trends:

Rising Prevalence of Chronic and Noncommunicable Diseases

Noncommunicable diseases account for approximately 80% of total deaths in Vietnam, with cardiovascular diseases, cancer, chronic respiratory conditions, and diabetes emerging as the leading causes of mortality. Moreover, diabetes affects approximately 7.1% of Vietnamese adults, equating to nearly 5 Million people, with this number projected to rise significantly in the coming years. The substantial disease burden is creating unprecedented demand for protein-based therapeutics, including insulin, monoclonal antibodies, and other biologics that offer targeted treatment approaches. Apart from this, cancer incidence is also rising significantly, with liver cancer accounting for 19.7% and lung cancer 17.7% of cases in men, while breast cancer leads at 28.9% in women. These epidemiological shifts are necessitating expanded access to advanced protein therapeutics, including immunotherapies, targeted monoclonal antibodies, and enzyme replacement therapies. The aging population is projected to increase, which is further amplifying demand for chronic disease management and protein-based treatments. Healthcare authorities have responded by establishing management protocols for NCDs at the grassroots level, with commune health stations managing up to 80% of people with mild or moderate NCDs using nationally standardized protocols. This integrated approach supports the Vietnam protein therapeutics market growth by improving access to essential biologics across urban and rural areas, ensuring that protein-based medications reach patients who require long-term therapeutic management for complex chronic conditions.

Expansion of Local Manufacturing and Research Capabilities

The market is increasingly benefiting from the expansion of local manufacturing and research infrastructure. Domestic pharmaceutical companies, often in collaboration with multinational partners, are investing in state-of-the-art facilities capable of producing recombinant proteins, monoclonal antibodies, and other complex biologics. This localized production not only reduces dependency on imports but also improves supply chain reliability and affordability for patients. Concurrently, research institutions and biotechnology startups are intensifying efforts in protein engineering, expression systems, and formulation development, which accelerates the introduction of innovative therapeutics into the market. Government incentives, including tax breaks and regulatory support for biotechnology and life sciences, are further encouraging investment in research and development. These developments foster a favorable ecosystem for both early-stage discovery and large-scale production, enabling faster translation of scientific innovations into commercially viable therapies. As a result, Vietnam is gradually positioning itself as a regional hub for protein therapeutics manufacturing and research.

Integration of Advanced Therapeutic Modalities

Another prominent trend facilitating the Vietnam protein therapeutics market growth is the integration of advanced therapeutic modalities, such as fusion proteins, PEGylated proteins, and antibody-drug conjugates, into clinical practice. These modalities enhance the pharmacokinetics, stability, and targeted action of protein-based medicines, making treatments more effective and reducing dosing frequency. The adoption of such advanced therapeutics is driven by the need for better patient compliance and improved management of chronic and complex diseases, including oncology and immunological disorders. Additionally, regulatory reforms and alignment with international standards have facilitated faster approvals and increased confidence among healthcare providers in adopting these innovative treatments. Vietnamese hospitals and specialty clinics are gradually incorporating these therapies into treatment protocols, supported by training programs for medical staff and awareness campaigns for patients. This trend underscores a shift toward precision medicine and reflects the market’s broader focus on offering tailored, high-efficacy protein therapeutics for diverse patient populations.

Vietnam Protein Therapeutics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on product, therapy area, and function.

Product Insights:

• Monoclonal Antibodies (mAbs)
• Human Insulin
• Erythropoietin
• Clotting Factors
• Fusion Protein
• Others

The report has provided a detailed breakup and analysis of the market based on the product. This includes monoclonal antibodies (mAbs), human insulin, erythropoietin, clotting factors, fusion protein, and others.

Therapy Area Insights:

• Metabolic Disorders
• Immunological Disorders
• Hematological Disorders
• Cancer
• Hormonal Disorders
• Genetic Disorders
• Others

A detailed breakup and analysis of the market based on the therapy area have also been provided in the report. This includes metabolic disorders, immunological disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others.

Function Insights:

• Enzymatic and Regulatory Activity
• Special Targeting Activity
• Vaccines
• Protein Diagnostics

The report has provided a detailed breakup and analysis of the market based on the function. This includes enzymatic and regulatory activity, special targeting activity, vaccines, and protein diagnostics.

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Vietnam Protein Therapeutics Market News:

• August 2025: Lupin has entered into a partnership with Sandoz Group AG to market and distribute biosimilar ranibizumab in multiple regions, including Vietnam. As part of the arrangement, Sandoz will manage commercialization in Vietnam, the European Union (except Germany), Switzerland, Norway, Australia, Hong Kong, and Malaysia, while Lupin will handle manufacturing and regulatory filings for the product.

Vietnam Protein Therapeutics Market Report Coverage:

Key Questions Answered in This Report:

• How has the Vietnam protein therapeutics market performed so far and how will it perform in the coming years?
• What is the breakup of the Vietnam protein therapeutics market on the basis of product?
• What is the breakup of the Vietnam protein therapeutics market on the basis of therapy area?
• What is the breakup of the Vietnam protein therapeutics market on the basis of function?
• What is the breakup of the Vietnam protein therapeutics market on the basis of region?
• What are the various stages in the value chain of the Vietnam protein therapeutics market?
• What are the key driving factors and challenges in the Vietnam protein therapeutics market?
• What is the structure of the Vietnam protein therapeutics market and who are the key players?
• What is the degree of competition in the Vietnam protein therapeutics market?

Key Benefits for Stakeholders:

• IMARC's industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Vietnam protein therapeutics market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Vietnam protein therapeutics market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Vietnam protein therapeutics industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.